Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 2/3 2Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Breast Neoplasms 27Lymphoma 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma, Non-Hodgkin 21Leukemia 21Multiple Myeloma 18Leukemia, Myeloid, Acute 18Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 16Myelodysplastic Syndromes 15Lymphoma, Mantle-Cell 15Lymphoma, Follicular 15Leukemia, Lymphocytic, Chronic, B-Cell 14Congenital Abnormalities 12Lymphoma, B-Cell, Marginal Zone 11Burkitt Lymphoma 11Primary Myelofibrosis 10Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Accelerated Phase 9Neoplasms, Plasma Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Recurrence 7Sezary Syndrome 6Myelodysplastic-Myeloproliferative Diseases 6Mycosis Fungoides 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6

Interventions

fludarabine phosphate 2Cyclosporine 2Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Methotrexate 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Anemia, Refractory × Cyclophosphamide × Clear all
NCT00255684 2016-11-03

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

University of Rochester

Phase NA Terminated
16 enrolled 6 charts
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡